Enzo & Farmingdale State College Partner on Campus COVID Testing

Long Island Headquartered Enzo Biochem, Inc. and Farmingdale State College have announced they are partnering to provide molecular and antibody testing for COVID-19 to the campus community as the college reopens this summer and begins classes in the fall.

LIBMI Mentor & CFB Advisor, Kara Cannon, Enzo’s Chief Commercial Officer commented, “Enzo is launching its School and Institution Testing (“SIT”) Program to ensure well-being, security, and compliance at educational and religious institutions. Farmingdale State College is the first to leverage Enzo’s expertise and enable this academic institution to safely forge a course forward this summer into the fall.”

Read the full press release on the partnership here.

Attend the Life Sciences Summit Virtually in November!

The Life Sciences Summit™ 2020 has gone digital! Join us online on November 17th & 18th as we spotlight the next wave of emerging companies. Our online event will continue to connect emerging biotech companies and academic innovators with the capital and strategic partners needed to move new discoveries into clinical development.

Save the date and visit lifesciencessummit.org for updates

If your organization is interested in presenting at the Summit, or if you would like sponsor the event, please contact Diane Fabel (diane.fabel@stonybrook.edu) or call 631.632.8521.

 

 

BARDA/Chembio Diagnostics Partner on COVID-19 Detection

BARDA and Chembio Diagnostics, Inc. are partnering to develop a point-of-care in vitro diagnostic test for the detection of SARS-CoV-2 in respiratory specimens.
This advanced lateral flow-based SARS-CoV-2 antigen detection test would run on the company’s proprietary platform. Learn more here.

The Center for Biotechnology is currently a member of the BARDA DRIVe accelerator network, helping to identify promising innovation and provide wraparound technical and business development support services.

“The Past, Present and Future of Infection Prevention”

A new white paper discussing responses to COVID-19 has been release by MIDI Medical Device Developers. The paper summarized the state of infection prevention pre-pandemic, existing solutions and promising innovations to tackle the outbreak. “The Past, Present and Future of Infection Prevention – Formulating the Response to COVID-19”

 

Webinar Recording: How BARDA is Investing $2B to Combat COVID-19

Our fellow BARDA DRIVe Accelerator, Life Science Washington Institute, has made available the recording of their recent webinar with BARDA detailing how the agency in investing to company COVID-19. Click the image to the webinar recording from June 4, 2020

Visit the Life Science Washington Institute webinar page for more information and links referenced in the webinar. https://www.lswinstitute.org/programs/drive-webinar/